CBLL Ceribell, Inc.

CBLL financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1861107 Exchange: Nasdaq SIC: 3845 (Electromedical & Electrotherapeutic Apparatus) Latest filing: 10-Q filed Aug 10, 2026 Data checked: Oct 21, 2026
Showing 3 of 3 annual and 0 of 11 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity Type
Operating
Public Float
$417.20M (Jun 2025)
Industry (SIC)
3845 Electromedical & Electrotherapeutic Apparatus
Incorporated
DE
Fiscal Year End
December (1231)
Phone
(800) 436-0826
EIN
471785452
Headquarters
SUNNYVALE, CA, 94085
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$101.96M
Net Income
$-66.00M
Total Assets
$166.35M
Total Equity
$128.31M
Total Debt
-
Free Cash Flow
$-54.72M
Ratios
Gross Margin
88.9%
Operating Margin
-68.6%
Net Margin
-64.7%
Return on Equity
-51.4%
Return on Assets
-39.7%
Current Ratio
9.18x
FCF / Assets
-32.9%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, Ceribell, Inc. recorded $89.06M of revenue, net loss of $53.41M, and an operating cash outflow of $40.81M. The $89.06M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Compared with $65.44M in fiscal 2024, revenue recorded a 36.1% year-over-year increase. Diluted earnings per share were -$1.46, translating the period’s attributable earnings into the amount reported for each diluted share. The diluted weighted-average share count was 36.54M, linking total earnings with the per-share result received by shareholders. At period end, total assets were $195.80M, framing the scale of the company’s operating and financing commitments. Revenue equaled 0.45x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $78.27M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 87.9% of revenue, showing how much of the top line remained after direct costs. The reported operating result was an operating loss of $58.40M, reflecting costs that exceeded gross profit. The operating loss equaled 65.6% of revenue, showing the scale of the operating deficit relative to sales. The bottom-line result was a net loss of $53.41M after operating, financing, tax, and other recognized items. Measured against revenue, the bottom-line deficit represented 60.0% after all recognized items. EBITDA was negative $57.40M, showing a deficit before interest, taxes, depreciation, and amortization. The pretax result was a loss of $53.41M, establishing the deficit before tax effects. The pretax loss equaled 60.0% of revenue, measuring the pre-tax deficit against sales. The company recognized $0.00 of income tax for the period, completing the transition from pretax income to net income. The loss-to-equity relationship was 34.4%, placing the bottom-line deficit against shareholder capital. The loss-to-assets relationship was 27.3%, placing the bottom-line deficit against the company’s resource base. Compared with a $40.45M net loss in fiscal 2024, the current loss increased to $53.41M.

Liquidity and Capital Structure

Total assets were $195.80M, supported by $40.47M of liabilities and $155.34M of shareholder equity. The near-term balance sheet paired $186.72M of current assets with $19.19M of current liabilities at the reporting date. At 9.73x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $40.48M, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 210.9%, excluding receivables and other current assets. Equity equaled 79.3% of assets, showing the shareholder-capital layer within the company’s balance sheet. The liabilities-to-assets relationship was 20.7%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 20.7% of total assets, showing the liquid cash component within the company’s broader resource base. Compared with $225.41M in fiscal 2024, the current asset base moved 13.1% and finished lower. Reported equity changed 18.7% from $191.16M in fiscal 2024, placing the current capital base lower year over year. The reported cash balance changed 79.2% from $194.37M in fiscal 2024, ending lower year over year.

Cash Flow and Earnings Quality

Operating activities used $40.81M of cash, resulting in an operating cash outflow for the year. Capital spending of $767.00K added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Operating cash flow and capital spending combined to leave a $41.58M cash deficit after capital spending. Free-cash-flow margin was -46.7%, reflecting a cash deficit equal to 46.7% of revenue after capital spending. Relative to total assets, the post-investment cash deficit measured 21.2%.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Ceribell, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $89.06M $65.44M $45.23M
Cost of Revenue $10.79M $8.69M $7.06M
Gross Profit $78.27M $56.75M $38.16M
OPERATING EXPENSES
R&D Expense $19.14M $13.56M $9.00M
SG&A Expense $44.45M $33.84M $20.29M
Other Operating Expenses (derived) $73.08M $49.06M $38.92M
Operating Income $-58.40M $-39.71M $-30.04M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $6.88M $2.74M $2.64M
Pretax Income $-53.41M $-40.46M $-29.45M
Income Tax $0 $0 $11.00K
Net Income $-53.41M $-40.46M $-29.46M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-1.46 $-3.39 $-5.56
Diluted Shares 36.54M 11.95M 5.30M
EBITDA $-57.40M $-39.01M $-29.54M
Depreciation & Amortization $1.00M $700.00K $500.00K
Balance Sheet
ASSETS
Cash & Equivalents $40.48M $194.37M $34.50M
Short-term Investments $118.79M - -
Accounts Receivable $15.05M $10.88M $7.96M
Inventory $7.29M $6.94M $5.87M
Other Current Assets $2.91M $3.25M $2.13M
Current Assets $186.72M $217.27M $51.96M
PP&E (Net) $2.03M $2.31M $1.58M
Other Noncurrent Assets $2.91M $2.19M $1.98M
Noncurrent Assets $9.09M $8.14M $6.96M
Total Assets $195.80M $225.41M $58.92M
LIABILITIES
Accounts Payable $2.84M $1.14M $732.00K
Other Current Liabilities $818.00K $609.00K $595.00K
Current Liabilities $19.19M $12.99M $21.60M
Other Noncurrent Liabilities $106.00K $356.00K $441.00K
Noncurrent Liabilities $21.28M $21.26M $2.16M
Total Liabilities $40.47M $34.25M $23.76M
EQUITY
Common Stock $38.00K $36.00K $5.00K
Additional Paid-in Capital $375.50M $358.07M $14.23M
Retained Earnings $-220.36M $-166.94M $-126.49M
Accumulated OCI $159.00K - -
Total Equity $155.34M $191.17M $35.16M
Total Liabilities & Equity $195.80M $225.41M $58.92M
SUPPLEMENTAL
Shares Outstanding 37.49M 35.85M 5.43M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-40.81M $-35.04M $-29.16M
Capital Expenditures $767.00K $1.34M $983.00K
Cash from Investing $-118.14M $-1.60M $-1.76M
Cash from Financing $5.05M $196.52M $-2.82M
Free Cash Flow $-41.58M $-36.38M $-30.14M
Beginning Cash (CFS) $194.37M $34.50M $68.24M
Net Change in Cash $-153.89M $159.88M $-33.74M
Effect of FX on Cash - - -
Calculated Ending Cash $40.48M $194.37M $34.50M
Cash per BS $40.48M $194.37M $34.50M
Cash scope difference (CFS − BS) - - -
Cash per CFS $40.48M $194.37M $34.50M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Ceribell, Inc.'s annual revenue?

Ceribell, Inc. reported $101.96M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Ceribell, Inc. profitable?

No. Ceribell, Inc. reported $-66.00M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does Ceribell, Inc. generate free cash flow?

No. Free cash flow was $-54.72M for trailing twelve months. Operating cash flow was $-54.03M.